VEGFA and age-related macular degeneration: With our linked clinicoimaging dataset, it would be possible to include image-derived outcomes, such as intraretinal fluid volume as well as subretinal fluid volume for DME and exudative AMD patients undergoing anti-vascular endothelial growth factor treatments, as well as GA lesion size for late-stage non-exudative AMD patients to monitor disease progression.